Reuters - Middle-aged people with low levels
of so-called good cholesterol may be at higher risk for memory
decline that could foreshadow Alzheimer's disease or other
forms of dementia, European researchers said on Monday.
Reuters - In overweight or obese
children, fatty liver disease appears to be a specific risk
factor for the metabolic syndrome, a precursor of heart disease
and diabetes, according to a study appearing in the American
Heart Association's journal Circulation.
AFP - So-called "good" cholesterol, known by its initials as HDL-C, plays an important role in maintaining memory in later life, according to a study published Monday.
ORLANDO, FL (UroToday.com) - Data is emerging about use of statins and risk reduction in development of prostate cancer (CaP). How do statins affect PSA? The authors previously observed that PSA levels decreased upon initiation of statin medications. In this report Hamilton and colleagues examined influence of statin drugs on PSA velocity in healthy men.
ORLANDO, FL (UroToday.com) - Data is emerging about use of statins and risk reduction in development of prostate cancer (CaP). How do statins affect PSA? The authors previously observed that PSA levels decreased upon initiation of statin medications. In this report Hamilton and colleagues examined influence of statin drugs on PSA velocity in healthy men.
Preliminary research culled from a national medical insurance records database in Taiwan suggests that sudden loss of hearing might be an early sign of vulnerability to stroke, foreshadowing an actual cerebrovascular event by as much as two years, according to a study reported in Stroke: Journal of the American Heart Association.
Morbidly obese patients who undergo a particular type of gastric bypass surgery called Roux-en-Y gastric bypass (RYGB) are at an increased risk of developing kidney stones - small, pebble-like deposits that can result in severe pain and require an operation to remove them - earlier than previously thought.
Weight-loss drug Rimonabant has been approved for use on the NHS. The National Institute for Health and Clinical Excellence (NICE) has announced the drug will be made available to overweight or obese people who have had no success with making life style changes or who cannot take the two other weight loss drugs Orlistat and Sibutramine.
A recent study found that about 10 percent of apparently healthy middle-aged participants with no symptoms of stroke were injured from “silent strokes,” researchers report in Stroke: Journal of the American Heart Association. Silent cerebral infarction (SCI), or “silent stroke,” is a brain injury likely caused by a blood clot interrupting blood flow in the brain.
A recent study found that about 10 percent of apparently healthy middle-aged participants with no symptoms of stroke were injured from “silent strokes,” researchers report in Stroke: Journal of the American Heart Association. Silent cerebral infarction (SCI), or “silent stroke,” is a brain injury likely caused by a blood clot interrupting blood flow in the brain.